Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public











Title  Creator  Group name  Publishing year 
PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1 Matheux et al. EquipeCG 2021-07-20
BAG6 promotes PINK1 signaling pathway and is essential for mitophagy Ragimbeau et al. EquipeCG 2021-02
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors Palassin et al. EquipeMY 2021
The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor Creusot et al. EquipeCG 2020-07-08
Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers Linares et al. EquipeVC 2019-07
A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/?-Catenin Pathway Grimaldi et al. PlateformePCC 2018
Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors Lapierre et al. EquipeMY Apr 12, 2016
Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line Badia et al. EquipeVC Sep 2016


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés